Connection

Catalin Baicu to Endothelin Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Catalin Baicu has written about Endothelin Receptor Antagonists.
Catalin Baicu
Connection Strength
0.112
Endothelin Receptor Antagonists
  1. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction. JACC Heart Fail. 2014 Apr; 2(2):123-30.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.